OEL Fastrac

Here at Affygility Solutions, we frequently engage in conversations with pharmaceutical professionals from all over the world regarding dedicated facilities and the underlying concepts of permissible daily exposures (PDEs), acceptable daily exposures (ADEs), and occupational exposure limits (OELs) for active pharmaceutical ingredients (1). Often, we field questions that are similar in nature and unfortunately just unsupported information, which I will call myths. These myths are as follows: Isn’t there some

Dimethyl Fumarate (DMF) requires advance handling precautions in an occupational exposure setting. IMPORTANT: Dimethyl fumarate (DMF) is a severe dermal sensitizer and advance handling precautions need to be taken before handling this compound in an occupational exposure setting. In addition, dimethyl fumarate is known to sublimate (going from the solid to gaseous phase without turning into a liquid). This has implications for containment, respiratory protection and industrial hygiene monitoring. The

Here at Affygility Solutions we often hear the statement, “We want it simple to use.” But, almost in the same breath, they will indicate “We want it comprehensive and want it to do this, this, and this” and “Oh, by the way does it work on iPhones, Android devices, and iPads?” As you can see, these statements presents a huge dichotomy and challenge for designers and developers that are tasked

Affygility Solutions is pleased to announce the immediate availability of five new OEL Fastrac monographs. These high-quality monographs not only include the occupational exposure limit (OEL), but also include the acceptable daily exposure (ADE) value. These new OEL Fastrac monographs include: Cidofovir Clobazam Cosyntropin Emtricitabine Exenatide Benefits of OEL Fastrac monographs with ADEs OEL Fastrac monographs offer the following benefits: Authoritative: Prepared by pharmaceutical industry experts with advance degrees, professional

Check out the latest in EHS compliance management software and OEL/ADE services Affygility Solutions will be exhibiting at the International Society for Pharmaceutical Engineers’ Proactive Compliance Conference to be held January 13-14, 2013 at the Hilton East Brunswick, New Jersey. Stop by and visit with Peter Burke to learn more about our EHS Compliance Management and Corrective Action Software, and our OEL Fastrac service – an affordable and innovative way

Affygility Solutions is pleased to announce the immediate availability of its Cyclophosphamide OEL Fastrac monograph. About Cyclophosphamide Cyclophosphamide is used in the treatment of a wide variety of cancers. Cyclophosphamide is a class of medications called alkylating agents and is of the nitrogen mustard type. Cyclophosphamide is an IARC Group 1 agent as a confirmed human carcinogen. In addition, cyclophosphamide has benn associated in experimental animal studies and human case

Affygility Solutions is pleased to announce that three new OEL Fastrac monographs have been posted up to the oelfastrac.com system. These three new OEL Fastrac monographs contain both the occupational exposure limit (OEL) and the acceptable daily exposure value (ADE). The 3 new OEL Fastrac monographs include: Sulfatrim Sulindac Talc OEL Fastrac monographs provide the following benefits: Access: Unsurpassed convenience. These documents are available to pharmaceutical companies and contract manufacturers

Occupational exposure limit (OEL) for Alfuzosin HCL Affygility Solutions is pleased to announce the immediate availability of the OEL Fastrac Monograph for Alfuzosin HCL. The FDA labeled indication for alfuzosin is treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Alfuzosin is an adrenergic alpha-antagonist. Alfuzosin exhibits selectivity for alpha1-adrenergic receptors in the lower urinary tract. Blockade of these adrenoreceptors can cause smooth muscle in the bladder neck and prostate to relax,

Hydroxyzine Occupational Exposure Limit (OEL) Now Immediately Available Affygility Solutions is pleased to announce the immediate availability of the OEL Fastrac monograph for hydroxyzine. Hydroxyzine, a piperazine derivative, is a sedating antihistamine with antimuscarinic and significant sedative properties; it is also an antiemetic. Hydroxyzine is mainly used in the treatment of anxiety prior to medical procedures, and for rash with itching. The most common adverse effects reported with taking hydroxyzine compounds

Affygility Solutions - provider of potent compound safety, webinars, and compliance management software